Bioreactors and Fermenters

Bioreactors and Fermenters

Global Bioreactors and Fermenters Market to Reach US$6.7 Billion by 2030

The global market for Bioreactors and Fermenters estimated at US$3.3 Billion in the year 2023, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Single-use Bioreactors, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Multiple-use Bioreactors segment is estimated at 9.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$844.1 Million While China is Forecast to Grow at 14.6% CAGR

The Bioreactors and Fermenters market in the U.S. is estimated at US$844.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 14.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Bioreactors and Fermenters Market - Key Trends & Drivers Summarized

What Role Do Bioreactors and Fermenters Play in Biotechnology?

Bioreactors and fermenters are critical tools used in biotechnology for the cultivation of microorganisms, cells, and tissues under controlled conditions. These devices are essential in the production of pharmaceuticals, vaccines, biofuels, and food products, among other biotechnological applications. Bioreactors provide the optimal environment for biological processes to take place, ensuring consistent growth and product yield. Fermenters, a type of bioreactor specifically designed for fermentation processes, are widely used in industries like biopharmaceuticals and bioenergy, where large-scale production of biologically derived substances is required. The increasing focus on biologics and sustainable bio-based products is driving the demand for advanced bioreactors and fermenters.

How Are Technological Advancements Shaping Bioreactor and Fermenter Design?

The design of bioreactors and fermenters has evolved significantly with advancements in materials, automation, and bioprocessing technology. Single-use bioreactors, for instance, have revolutionized the industry by offering a more flexible and cost-effective alternative to traditional stainless-steel systems. These disposable systems reduce the risk of contamination and eliminate the need for complex cleaning and sterilization protocols. Additionally, bioreactors equipped with advanced sensors and process control systems enable real-time monitoring and optimization of conditions such as pH, temperature, and oxygen levels. Continuous bioprocessing technologies are also gaining traction, allowing for more efficient, uninterrupted production processes, particularly in the biopharmaceutical industry.

Which Industries Are Driving the Growth of the Bioreactors and Fermenters Market?

The pharmaceutical and biopharmaceutical industries are the primary drivers of the bioreactors and fermenters market, particularly with the increasing production of biologics and biosimilars. The shift toward personalized medicine and gene therapies, which require scalable and precise cell culture systems, has further accelerated the demand for these devices. Additionally, the bioenergy sector, focused on the production of biofuels and bio-based chemicals, is contributing to market growth, as fermenters are integral to the production of ethanol and other bio-based products. The food and beverage industry also relies heavily on fermenters for the production of fermented goods like beer, wine, and dairy products.

The growth in the bioreactors and fermenters market is driven by several factors, including the increasing demand for biologics and biosimilars, advancements in bioprocessing technologies, and the rising focus on sustainability in bio-based product manufacturing. The shift toward single-use bioreactors in the biopharmaceutical industry is a significant driver, as these systems offer greater flexibility and lower capital investment. Additionally, the growing bioenergy sector and the push for renewable energy sources are creating new opportunities for fermenters in biofuel production. The increasing adoption of automation and real-time monitoring technologies is further enhancing the efficiency and scalability of bioreactors, supporting the market’s growth trajectory.

Select Competitors (Total 41 Featured) -

• Applikon Biotechnology BV
• Danaher Corporation
• Finesse Solutions, Inc.
• GE Healthcare
• PBS Biotech, Inc.
• Pierre Guerin SAS
• SOLARIS BIOTECHNOLOGY srl
• Zeta Holding GmbH

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.